| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.0071 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |